At the Center for Interventional Psychiatry, we are committed to offering our patients the latest advancements in mental health treatments while assuring them of the highest level of quality and safety.
Ketamine is an anesthetic medicine that has been in use for many decades and is on the World Health Organization's list of essential medicines. It also has been shown to be effective in treating depression, especially in patients who have not responded to traditional treatment options. In 2019, our center was approved to administer ketamine treatment services to treat patients with major depression.
Our ketamine treatment services can provide fast relief from major depressive symptoms, including suicidal thoughts. They are available to adults age 18 and older who have not had success with traditional treatments for depression.
Studies show that the drug ketamine modulates the neurochemical glutamate. This prompts the brain to form new neural connections in a complex and cascading series of events. The brain becomes more adaptable and able to create new pathways — and helps you develop more positive thoughts and behaviors.
We currently offer:
Esketamine is a nasal spray derived from ketamine. It recently was approved by the U.S. Food and Drug Administration (FDA) for use in health care settings to treat severe depression.
EsKIT is administered in a clinical setting. You will be carefully monitored during and after treatment to watch for any possible side effects. During your treatment, your blood pressure, heart rate, and oxygen will be monitored.
For more information or to schedule an appointment with the Center for Interventional Psychiatry, please call 412-246-5063.
Your health information, right at your fingertips. Select MyUPMC to access your UPMC health information. For patients of UPMC-affiliated doctors in Central Pa, select UPMC Central Pa Portal. Patients of UPMC Cole should select the UPMC Cole Connect Patient Portal.